FDA Adverse Event Malfunction Summary report: N

VITROS ECIQ IMMUNODIAGNOSTIC SYSTEM

MDR report key: 2181646 · Received July 27, 2011

Report

Report Number
1319681-2011-00149
Event Type
Malfunction
Date Received
July 27, 2011
Date of Event
June 27, 2011
Report Date
July 27, 2011
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
Product Code
LFX
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION INTO THIS EVENT DETERMINED THAT MULTIPLE, NON-REPRODUCIBLE VITROS ANTI-HBS (AHBS) AND RUBELLA IGG (RUB G) PATIENT RESULTS WERE OBTAINED. AN OCD FIELD ENGINEER PERFORMED "AS NEEDED" SERVICE TO THE REAGENT METERING AND WELL WASH SUBSYSTEMS ON THE VITROS ECIQ ANALYZER. PERFORMANCE TESTING FOLLOWING SERVICE VERIFIED THAT THE EQUIPMENT WAS RETURNED TO EXPECTED OPERATION. THE ASSIGNABLE ROOT CAUSE WAS AN INSTRUMENT RELATED ISSUE.

Description of Event or Problem · 1

THE CUSTOMER OBTAINED MULTIPLE NON-REPRODUCIBLE VITROS ANTI-HBS (AHBS) AND RUBELLA IGG (RUB G) PATIENT RESULTS WHILE USING THE VITROS ECIQ IMMUNODIAGNOSTIC SYSTEM. VITROS AHBS RESULTS FOR A SINGLE PATIENT SAMPLE GAVE THE FOLLOWING RESULTS: (B)(6). VITROS RUBELLA RESULTS FOR FIVE PATIENT SAMPLES WERE AFFECTED: PATIENT 1 RUB G RESULT OF 6.45 IU/ML (NEGATIVE) VS. 219 & 162 IU/ML (POSITIVE). PATIENT 2 RUB G RESULT OF 6.98 IU/ML (NEGATIVE) VS. 99.6 IU/ML (POSITIVE). PATIENT 3 RUB G RESULT OF 22.9 IU/ML (POSITIVE) VS. 8.29 IU/ML (NEGATIVE). PATIENT 4 RUB G RESULT OF 9.71 IU/ML (NEGATIVE) VS. 93.0 IU/ML (POSITIVE). PATIENT 5 RUB G RESULT OF 2.3 IU/ML (NEGATIVE) VS. 34.1 & 26.8 IU/ML (POSITIVE). BIASED RESULTS OF THE DIRECTION AND MAGNITUDE OBSERVED COULD LEAD TO INAPPROPRIATE PHYSICIAN ACTION. NO AFFECTED PATIENT RESULTS WERE REPORTED TO CLINICIAN. THERE WAS NO REPORT OF PATIENT HARM AS A RESULT OF THIS EVENT. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITROS ECIQ IMMUNODIAGNOSTIC SYSTEM IMMUNODIAGNOSTIC ANALYZER LFX ORTHO-CLINICAL DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1